Search Within

Tiffany A Traina

  1. "Mark Robson"
Formats
  1. Meeting Abstract (14)
  2. Journal Article (12)
  3. Review (1)
Groups
  1. Breast Medicine Service (27)
  2. Department of Medicine (27)
  3. Population Sciences Research Program (27)
  4. Solid Tumor Oncology Division (27)
  5. Survivorship Research (27)
  6. Biostatistics Service (20)

More Groups

People
  1. Mark Robson (27)
  2. Sujata Patil (12)
  3. Larry Norton (10)
  4. Jorge Reis-Filho (9)
  5. Chau Dang (8)
  6. Clifford Hudis (7)

More People

Years
  1. 2024 (3)
  2. 2023 (2)
  3. 2022 (1)
  4. 2021 (4)
  5. 2020 (5)
  6. 2018 (2)

More Years

Publications
  1. Journal of Clinical Oncology (5)
  2. Cancer Research (4)
  3. International Journal of Radiation Oncology, Biology, Physics (3)
  4. Breast Cancer Research and Treatment (2)
  5. Cochrane Database of Systematic Reviews (2)
  6. Laboratory Investigation (2)

More Publications

Publishers
  1. American Association for Cancer Research (5)
  2. American Society of Clinical Oncology (5)
  3. Elsevier Inc. (3)
  4. Nature Publishing Group (3)
  5. Springer (3)
  6. John Wiley & Sons (2)

More Publishers

Results (27)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Favorable prognosis in patients with T1a/T1bN0 triple-negative breast cancers treated with multimodality therapy
    Journal Article

    Ho, A. Y.; Gupta, G.; King, T. A.; Perez, C. A.; Patil, S. M.; Rogers, K. H.; Wen, Y. H.; Brogi, E.; Morrow, M.; Hudis, C. A.; more...
    Cancer (2012)

    Fulltext@MSK | Save
  • Favorable prognosis in patients with T1a,b node-negative triple negative breast cancers treated with multimodality therapy
    Meeting Abstract

    Ho, A. Y.; Gupta, G.; Perez, C. A.; King, T. A.; Pati, S. M.; Rogers, K. H.; Brogi, E.; Morrow, M.; Hudis, C.; Traina, T.; more...
    Cancer Research (2011)

    Fulltext@MSK | Save
  • Black race is associated with higher risk of locoregional recurrence after breast-conserving therapy in patients with triple negative breast cancer
    Meeting Abstract

    Perez, C. A.; Gupta, G.; King, T. A.; Rogers, K. H.; McLane, A.; Patil, S.; Traina, T. A.; Robson, M.; McCormick, B.; Ho, A. Y.
    International Journal of Radiation Oncology, Biology, Physics (2011)

    Fulltext@MSK | Save
  • A feasibility study of bevacizumab plus dose-dense doxorubicin- cyclophosphamide (AC) followed by nanoparticle albumin-bound paclitaxel in early-stage breast cancer
    Journal Article

    Mcarthur, H. L.; Rugo, H.; Nulsen, B.; Hawks, L.; Grothusen, J.; Melisko, M.; Moasser, M.; Paulson, M.; Traina, T.; Patil, S.; more...
    Clinical Cancer Research (2011)

    Fulltext@MSK | Save
  • Feasibility trial of letrozole in combination with bevacizumab in patients with metastatic breast cancer
    Journal Article

    Traina, T. A.; Rugo, H. S.; Caravelli, J. F.; Patil, S.; Yeh, B.; Melisko, M. E.; Park, J. W.; Geneus, S.; Paulson, M.; Grothusen, J.; more...
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Dose-dense (DD) doxorubicin and cyclophosphamide (AC) followed by weekly paclitaxel (P) with trastuzumab (T) and lapatinib (L) in HER2/neu-positive breast cancer is not feasible due to excessive diarrhea: Updated results
    Meeting Abstract

    Dang, C.; Lin, N.; Moy, B.; Come, S.; Lake, D.; Theodoulou, M.; Troso-Sandoval, T.; Dickler, M.; Gorsky, M.; D'Andrea, G.; more...
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Pharmacokinetics and tolerability of exemestane in combination with raloxifene in postmenopausal women with a history of breast cancer
    Journal Article

    Traina, T. A.; Poggesi, I.; Robson, M.; Asnis, A.; Duncan, B. A.; Heerdt, A.; Dang, C.; Lake, D.; Moasser, M.; Panageas, K.; more...
    Breast Cancer Research and Treatment (2008)

    Fulltext@MSK | Save